Source: Annual Congress 2009 - Aetiology and diagnosis of lower respiratory tract infections
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
A. Gurgun, M. S. Tasbakan, Y. Ceviker, D. Metin, H. Pullukcu, S. Citim, O. K. Basoglu, S. Hilmioglu, F. Bacaklogu (Izmir, Turkey). Our patients of candida and aspergillus pneumonia. Eur Respir J 2009; 34: Suppl. 53, 2408

Member's Comments

No comment yet.

Related content which might interest you: Treatment outcome in patients with chronic pulmonary aspergillosis by azole-resistant aspergillus fumigatus Source: International Congress 2016 – Severe respiratory infections in the intensive care unit and pleural and fungal infections Year: 2016 Nocardia community-acquired pneumonia in immunocompetent and immunocompromised host Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Outbreak of pneumocystis jiroveci pneumonia among renal transplant patients Source: Annual Congress 2013 –Respiratory infections: a combination of problems needing early treatment Year: 2013 Invasive aspergillus tracheobronchitis (AT) in non-neutropenic, immunocompromised patients Source: Annual Congress 2008 - Rare clinical cases Year: 2008 Pleural empyema in acute bacterial pneumonia in children Source: Eur Respir J 2004; 24: Suppl. 48, 715s Year: 2004 Necrotising pneumonia in children Source: Annual Congress 2007 - Why is complicated pneumonia and empyema increasing so rapidly in children? Year: 2007 COVID-19 and complicated bacterial pneumonia in children Source: ERJ Open Res, 7 (1) 00884-2020; 10.1183/23120541.00884-2020 Year: 2021 Necrotising pneumonia is an increasingly detected complication of pneumonia in children Source: Eur Respir J 2008; 31: 1285-1291 Year: 2008 The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Prevalence of atypical bacterial pathogens in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2013 –Difficult and rare respiratory infections Year: 2013 Pulmonary infections in neutropenic patients Source: Eur Respir J 2003; 22: Suppl. 45, 334s Year: 2003 Usefulness of alveoloscopy in the diagnosis pf Pneumocystis jiroveci pneumonia in HIV+ patients Source: Annual Congress 2009 - Aetiology and treatment of community-acquired pneumonia Year: 2009 Prognosis of pneumocystis jirovecii pneumonia in non-HIV patients Source: Annual Congress 2013 –Manifestations, scores and prognosis of community-acquired pneumonia Year: 2013 Frequency of candida species mycoses isolation from patients with pulmonary tuberculosis Source: Eur Respir J 2004; 24: Suppl. 48, 422s Year: 2004 Common pathogens in bronchial secretions of the ICU patients with nosocomial pneumonia Source: Eur Respir J 2001; 18: Suppl. 33, 405s Year: 2001 Nontuberculous mycobacterial disease and Aspergillus-related lung disease in bronchiectasis Source: Eur Respir J 2006; 28: 352-357 Year: 2006 Disseminated bacterial community-acquired pneumonia in patients at late stages of HIV infection Source: International Congress 2019 – Prognosis in bacterial and viral pneumonia Year: 2019 Detection parachlamydia acanthamoeba and simkania negevensis in young patients with community-acquired pneumonia (CAP) Source: Eur Respir J 2004; 24: Suppl. 48, 412s Year: 2004